Japanese Journal of Clinical Oncology Advance Access originally published online on April 24, 2009
Japanese Journal of Clinical Oncology 2009 39(7):456-459; doi:10.1093/jjco/hyp034
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author (2009). Published by Oxford University Press. All rights reserved
Relapse with Malignant Transformation After Chemotherapy for Primary Mediastinal Seminoma: Case Report
Division of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
For reprints and all correspondence: Yasuhiro Fujiwara, Division of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. E-mail: yfujiwar{at}ncc.go.jp
Received July 29, 2008; accepted March 19, 2009
This case report details a relapse with malignant transformation after the completion of bleomycin, etoposide and cisplatin chemotherapy for primary mediastinal seminoma, although the residual mass after chemotherapy was <3 cm in size and did not display an increased uptake of fluorodeoxyglucose when examined using positron emission tomography.
Key Words: germ cell tumor seminoma relapse malignant transformation mediastinum